Literature DB >> 15069676

Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960.

Fabio Levi1, Franca Lucchini, Eva Negri, Peter Boyle, Carlo La Vecchia.   

Abstract

Mortality data, abstracted from the World Health Organization database, are presented in tabular form for 26 cancer sites or groups of sites, plus total cancer mortality, in 36 European countries during the period 1995-1999. Trends in mortality are also given in graphic form for 23 major countries plus the European Union as a whole over the period 1960-1999. In the European Union, total cancer mortality declined by 7% for both sexes over the last 5 years considered. The fall since the late 1980s was 10% in both sexes, corresponding to the avoidance of over 90000 deaths per year, as compared to the rates of the late 1980s. For the first time, over the last few years, some leveling of mortality was reported also in the Russian Federation, the Czech Republic, Poland, Hungary and other Eastern European countries, although cancer rates in those areas remain exceedingly high. The overall favorable pattern of cancer mortality over recent years is largely driven by the decline of tobacco-related cancer mortality in men. However, important components of the trends are also the persistence of substantial falls in gastric cancer, mainly in Russia and Eastern Europe, the recent decline in intestinal cancer in both sexes and of breast cancer in women, together with the long-term falls in uterine (cervical) cancer, leukemias, Hodgkin's disease and other neoplasms amenable to advancements in diagnosis and treatment. Female lung cancer mortality has been declining in the Russian Federation, but is still rising in other areas of the continent. Thus, urgent intervention is needed to bring under control the tobacco-related lung cancer epidemic in European women before it reaches the high level observed in North America. Supplementary material for this article can be found on the International Journal of Cancer website at http://www.interscience.wiley.com/jpages/0020-7136/suppmat/index.html Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15069676     DOI: 10.1002/ijc.20097

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  36 in total

1.  The Validity and Reliability of Health Belief Scale for Testicular Cancer Self-Examination.

Authors:  Ilknur Aydin Avci; Busra Altinel
Journal:  Am J Mens Health       Date:  2015-10-18

2.  Central and Eastern European experience with sunitinib in metastatic renal cell carcinoma: a sub-analysis of the global expanded-access trial.

Authors:  Eduard Vrdoljak; Lajos Géczi; Jozef Mardiak; Tudor-Eliade Ciuleanu; Sophie Leyman; Ke Zhang; Peter Sajben; Laszlo Torday
Journal:  Pathol Oncol Res       Date:  2015-01-04       Impact factor: 3.201

3.  Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.

Authors:  Ingemar Turesson; Ramon Velez; Sigurdur Y Kristinsson; Ola Landgren
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

4.  Interleukin 8 (IL-8) - a universal biomarker?

Authors:  Aamir Shahzad; Martin Knapp; Irene Lang; Gottfried Köhler
Journal:  Int Arch Med       Date:  2010-06-15

5.  Convergence with SEER database achieved by a breast cancer network: a longitudinal benchmark of 5-year relative survival.

Authors:  Christian O Jacke; Ute S Albert; Iris Reinhard; Matthias Kalder
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-16       Impact factor: 4.553

6.  Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.

Authors:  Marcello F Fanelli; Milton J B Silva; Tadeu F de Paiva; Ludmilla T D Chinen; Andréa P G Guimarães; Daniel L Gimenes; Edilson D Pinheiro; José A Rinck; Ulisses R Nicolau; Solange M Sanches; Celso A L Melo; Aldo L A Dettino; Marcelo R S Cruz; Leila Maria M P de Melo; Maria N C Formiga; Vladmir C C de Lima
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

7.  Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma.

Authors:  Erik E Johnson; Brett H Yamane; Ilia N Buhtoiarov; Hillary D Lum; Alexander L Rakhmilevich; David M Mahvi; Stephen D Gillies; Paul M Sondel
Journal:  Clin Cancer Res       Date:  2009-07-28       Impact factor: 12.531

8.  Effective diameter of balloon dilation for benign esophagojejunal anastomotic stricture after total gastrectomy.

Authors:  Chan Gyoo Kim; Il Ju Choi; Jong Yeul Lee; Soo-Jeong Cho; Jun Ho Lee; Keun Won Ryu; Sook Ryun Park; Jae-Moon Bae; Young-Woo Kim
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

9.  Trends in Mortality Rates for Gastrointestinal Cancers in Fars Province, Iran (2005-2015).

Authors:  Hossein-Ali Nikbakht; Sadaf Sahraian; Haleh Ghaem; Afshan Javadi; Maryam Janfada; Soheil Hassanipour; Ali-Reza Mirahmadizadeh
Journal:  J Gastrointest Cancer       Date:  2020-03

10.  Blockage of transdifferentiation from fibroblast to myofibroblast in experimental ovarian cancer models.

Authors:  Qin Yao; Xun Qu; Qifeng Yang; David A Good; Shuzhen Dai; Beihua Kong; Ming Q Wei
Journal:  Mol Cancer       Date:  2009-09-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.